This is the home of Melbourne Bioanalytics, an Australian research group specialising in metabolomics, genomics and microbiomics research into Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

ME/CFS is a severe, chronic and disabling multisystem disease which affects an estimated 240,000 Australians, and as many as 17 million people worldwide. For many the condition will be lifelong, limiting their ability to work, study or even leave their beds. There is currently no diagnostic test, nor cure for the disease.

ME/CFS research is underfunded globally. Research funding for similarly disabling conditions is 25 times higher than funding for ME/CFS research. In Australia, biomedical research into ME/CFS has received no federal government funding since 2005.

Make a donation to help Melbourne Bioanalytics continue their ground-breaking work into ME/CFS.

This website is run by patients, to promote and raise much needed funds for the research work of Melbourne Bioanalytics.